Statistics

Total Visits

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study93

Select a period of time:

Number of views in the range

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study36

Views

Views
June 20255
July 202513
August 20254
September 20256
October 20253
November 20255
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil14
United States12
Hong Kong2
Argentina1
Austria1
Ecuador1
Egypt1
United Kingdom1
Morocco1
Paraguay1
 

Top cities views

Views
Hong Kong2
Americana1
Belo Horizonte1
Cairo1
Canton1
Casablanca1
Caxias do Sul1
Ciudad del Este1
Contagem1
Estância Velha1